Amprius Technologies, Inc. (AMPX) · Insider trading
What Amprius Technologies's directors, officers and largest holders bought and sold themselves, from the Form 4 each of them files with the SEC within two business days of a trade. Open-market purchases and sales first: those are the trades somebody chose to make at the market price.
Bought, 12 months
$0
0 insiders, 0 trades
Sold, 12 months
$85.69M
6 insiders, 0% under a plan
Net, 12 months
−$85.69M
bought less sold
Latest filing
2026-08-25
filings read to 2026-10-19
Who traded, two years
| Insider | Bought | Sold | Trades | Last trade | Holds after |
|---|---|---|---|---|---|
| Sun KangDirector | – | $58.42M | 17 | 2026-08-21 | 1,218,397 |
| Stefan Constantin IonelChief Technology Officer | – | $10.92M | 14 | 2026-08-21 | 771,629 |
| Hsieh Wen HsuanDirector | – | $7.62M | 2 | 2026-03-12 | 175,090 |
| Chu StevenDirector | – | $5.86M | 4 | 2026-03-12 | 182,904 |
| Dixon Donald RDirector | – | $2.54M | 3 | 2026-06-15 | – |
| Stepien Thomas MDirector, Chief Executive Officer | – | $1.34M | 5 | 2026-08-24 | 594,096 |
| Bornstein JonathanPresident of Amprius Lab | – | $363,742 | 4 | 2025-02-21 | 419,197 |
| Wallach SandraChief Financial Officer | – | $351,090 | 4 | 2025-08-21 | 1,005,275 |
Open-market purchases and sales
Newest first. “Plan” marks a trade made under a 10b5-1 plan set up in advance.
| Date | Insider | Trade | Shares | Price | Value | Holds after | Filing |
|---|---|---|---|---|---|---|---|
| 2026-08-24 | Stepien Thomas MDirector, Chief Executive Officer | Sale | 8,000 | 10.03 | $80,240 | 594,096 | Form 4 |
| 2026-08-21 | Sun KangDirector | Sale | 62,101 | 10.34 | $642,124 | 1,218,397 | Form 4 |
| 2026-08-21 | Stefan Constantin IonelChief Technology Officer | Sale | 29,681 | 10.34 | $306,902 | 771,629 | Form 4 |
| 2026-08-21 | Stepien Thomas MDirector, Chief Executive Officer | Sale | 23,529 | 10.34 | $243,290 | 602,096 | Form 4 |
| 2026-06-15 | Dixon Donald RDirector | Saleindirect | 85,000 | 17.17 | $1.46M | 359,380 | Form 4 |
| 2026-06-09 | Dixon Donald RDirector | Saleindirect | 40,000 | 19.13 | $765,200 | 444,380 | Form 4 |
| 2026-06-04 | Stepien Thomas MDirector, Chief Executive Officer | Sale | 2,000 | 20.97 | $41,940 | 625,625 | Form 4 |
| 2026-05-27 | Sun KangDirector | Sale | 356 | 17.19 | $6,120 | 1,280,498 | Form 4 |
| 2026-05-27 | Stefan Constantin IonelChief Technology Officer | Sale | 3,208 | 17.19 | $55,146 | 801,310 | Form 4 |
| 2026-05-27 | Stepien Thomas MDirector, Chief Executive Officer | Sale | 4,375 | 17.19 | $75,206 | 694,923 | Form 4 |
| 2026-05-26 | Dixon Donald RDirector | Saleindirect | 17,895 | 17.90 | $320,320 | 484,380 | Form 4 |
| 2026-05-21 | Sun KangDirector | Sale | 67,796 | 14.79 | $1.00M | 1,280,854 | Form 4 |
| 2026-05-21 | Stefan Constantin IonelChief Technology Officer | Sale | 28,812 | 14.79 | $426,129 | 804,518 | Form 4 |
| 2026-05-21 | Stepien Thomas MDirector, Chief Executive Officer | Sale | 60,702 | 14.79 | $897,783 | 699,298 | Form 4 |
| 2026-04-01 | Sun KangDirector | Sale | 1,250,963 | 15.73 | $19.68M | 1,591,437 | Form 4 |
| 2026-04-01 | Sun KangDirector | Sale | 249,037 | 16.78 | $4.18M | 1,342,400 | Form 4 |
| 2026-03-23 | Sun KangDirector | Saleindirect | 152,823 | 18.69 | $2.86M | 121,452 | Form 4 |
| 2026-03-23 | Sun KangDirector | Saleindirect | 65,046 | 19.06 | $1.24M | 56,406 | Form 4 |
| 2026-03-12 | Hsieh Wen HsuanDirector | Sale | 282,500 | 18.55 | $5.24M | 175,090 | Form 4 |
| 2026-03-12 | Hsieh Wen HsuanDirector | Sale | 130,646 | 18.22 | $2.38M | 44,444 | Form 4 |
| 2026-03-12 | Chu StevenDirector | Sale | 100,000 | 18.65 | $1.86M | 182,904 | Form 4 |
| 2026-03-12 | Chu StevenDirector | Sale | 50,000 | 18.21 | $910,500 | 132,904 | Form 4 |
| 2026-03-12 | Chu StevenDirector | Sale | 5,565 | 18.53 | $103,119 | 127,339 | Form 4 |
| 2026-03-10 | Chu StevenDirector | Sale | 166,632 | 17.92 | $2.99M | 127,339 | Form 4 |
| 2026-02-23 | Sun KangDirector | Sale | 61,251 | 10.16 | $622,310 | 1,342,400 | Form 4 |
| 2026-02-23 | Stefan Constantin IonelChief Technology Officer | Sale | 25,366 | 10.16 | $257,719 | 723,330 | Form 4 |
| 2026-01-28 | Stefan Constantin IonelChief Technology Officer | Sale | 39,690 | 12.00 | $476,280 | 748,696 | Form 4 |
| 2026-01-23 | Stefan Constantin IonelChief Technology Officer | Sale | 1,600 | 12.00 | $19,200 | 748,696 | Form 4 |
| 2026-01-22 | Stefan Constantin IonelChief Technology Officer | Sale | 492,827 | 12.04 | $5.93M | 748,696 | Form 4 |
| 2026-01-21 | Stefan Constantin IonelChief Technology Officer | Sale | 73,280 | 12.00 | $879,360 | 748,696 | Form 4 |
| 2026-01-20 | Sun KangDirector | Sale | 43,185 | 11.03 | $476,331 | 1,403,651 | Form 4 |
| 2026-01-16 | Sun KangDirector | Sale | 950,548 | 11.07 | $10.52M | 1,403,651 | Form 4 |
| 2026-01-12 | Sun KangDirector | Sale | 506,267 | 10.10 | $5.11M | 1,403,651 | Form 4 |
| 2025-12-11 | Stefan Constantin IonelChief Technology Officer | Sale | 198,255 | 10.51 | $2.08M | 748,696 | Form 4 |
| 2025-11-21 | Sun KangDirector, Chief Executive Officer | Sale | 68,655 | 10.08 | $692,042 | 1,403,651 | Form 4 |
| 2025-11-21 | Stefan Constantin IonelChief Technology Officer | Sale | 25,024 | 10.08 | $252,242 | 821,951 | Form 4 |
| 2025-11-17 | Sun KangDirector, Chief Executive Officer | Sale | 1,000,000 | 10.60 | $10.60M | 1,472,306 | Form 4 |
| 2025-08-21 | Sun KangDirector, Chief Executive Officer | Sale | 65,654 | 6.82 | $447,760 | 1,472,306 | Form 4 |
| 2025-08-21 | Wallach SandraChief Financial Officer | Sale | 28,390 | 6.82 | $193,620 | 1,005,275 | Form 4 |
| 2025-08-21 | Stefan Constantin IonelChief Technology Officer | Sale | 19,159 | 6.82 | $130,664 | 846,975 | Form 4 |
13 more
| 2025-05-21 | Sun KangDirector, Chief Executive Officer | Sale | 69,786 | 2.43 | $169,580 | 1,812,235 | Form 4 |
| 2025-05-21 | Wallach SandraChief Financial Officer | Sale | 27,595 | 2.43 | $67,056 | 1,033,665 | Form 4 |
| 2025-05-21 | Stefan Constantin IonelChief Technology Officer | Sale | 20,366 | 2.43 | $49,489 | 866,134 | Form 4 |
| 2025-02-21 | Sun KangDirector, Chief Executive Officer | Sale | 34,353 | 3.13 | $107,525 | 1,282,621 | Form 4 |
| 2025-02-21 | Wallach SandraChief Financial Officer | Sale | 18,142 | 3.13 | $56,784 | 678,000 | Form 4 |
| 2025-02-21 | Stefan Constantin IonelChief Technology Officer | Sale | 9,066 | 3.13 | $28,377 | 421,489 | Form 4 |
| 2025-02-21 | Bornstein JonathanPresident of Amprius Lab | Sale | 13,527 | 3.13 | $42,340 | 419,197 | Form 4 |
| 2024-11-21 | Sun KangDirector, Chief Executive Officer | Sale | 33,779 | 1.96 | $66,207 | 1,316,974 | Form 4 |
| 2024-11-21 | Wallach SandraChief Financial Officer | Sale | 17,158 | 1.96 | $33,630 | 696,142 | Form 4 |
| 2024-11-21 | Stefan Constantin IonelChief Technology Officer | Sale | 8,575 | 1.96 | $16,807 | 430,555 | Form 4 |
| 2024-11-21 | Bornstein JonathanPresident of Amprius Lab | Saleindirect | 15,000 | 1.96 | $29,400 | 1,040,950 | Form 4 |
| 2024-11-21 | Bornstein JonathanPresident of Amprius Lab | Sale | 18,170 | 1.96 | $35,613 | 454,131 | Form 4 |
| 2024-11-20 | Bornstein JonathanPresident of Amprius Lab | Saleindirect | 133,536 | 1.92 | $256,389 | 1,039,187 | Form 4 |
Grants, exercises and other transactions
Pay, tax and paperwork rather than a choice to trade at the market price. Two years.
28 × option exercise20 × grant or award7 × gift2 × other
Show them
| Date | Insider | What | Shares | Price | Holds after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-25 | Stepien Thomas MDirector, Chief Executive Officer | Gift G | −5,000 | – | 589,096 | Form 4 |
| 2026-08-25 | Stepien Thomas MDirector, Chief Executive Officer | Gift G | −5,000 | – | 584,096 | Form 4 |
| 2026-08-25 | Stepien Thomas MDirector, Chief Executive Officer | Gift G | −5,000 | – | 579,096 | Form 4 |
| 2026-08-25 | Stepien Thomas MDirector, Chief Executive Officer | Gift G | −346 | – | 578,750 | Form 4 |
| 2026-08-25 | Stepien Thomas MDirector, Chief Executive Officer | Grant or award A | +346 | – | 37,260 | Form 4 |
| 2026-06-12 | Dixon Donald RDirector | Grant or award A | +10,423 | – | 280,079 | Form 4 |
| 2026-06-12 | Bayless Kathleen ADirector | Grant or award A | +10,423 | – | 216,120 | Form 4 |
| 2026-06-12 | Chu StevenDirector | Grant or award A | +10,423 | – | 137,762 | Form 4 |
| 2026-06-12 | Satterthwaite LivingstonDirector | Grant or award A | +10,423 | – | 346,506 | Form 4 |
| 2026-06-04 | Stepien Thomas MDirector, Chief Executive Officer | Gift G | −30,384 | – | 664,539 | Form 4 |
| 2026-06-04 | Stepien Thomas MDirector, Chief Executive Officer | Gift G | −36,914 | – | 627,625 | Form 4 |
| 2026-06-04 | Stepien Thomas MDirector, Chief Executive Officer | Gift G | +36,914 | – | 36,914 | Form 4 |
| 2026-05-05 | Sun KangDirector | Grant or award A | +6,250 | – | 1,348,650 | Form 4 |
| 2026-04-01 | Sun KangDirector | Option exercise M | +1,312,505 | 1.78 | 2,654,905 | Form 4 |
| 2026-04-01 | Sun KangDirector | Option exercise M | +187,495 | 3.68 | 2,842,400 | Form 4 |
| 2026-03-12 | Hsieh Wen HsuanDirector | Option exercise M | +270,251 | 2.61 | 457,590 | Form 4 |
| 2026-03-12 | Chu StevenDirector | Option exercise M | +86,143 | 2.61 | 213,482 | Form 4 |
| 2026-03-12 | Chu StevenDirector | Option exercise M | +69,422 | 0.62 | 282,904 | Form 4 |
| 2026-03-10 | Chu StevenDirector | Option exercise M | +104,132 | 0.62 | 293,971 | Form 4 |
| 2026-03-04 | Rodriguez Ricardo C.Chief Financial Officer | Grant or award A | +150,000 | – | 350,000 | Form 4/A |
| 2026-03-04 | Stefan Constantin IonelChief Technology Officer | Grant or award A | +110,000 | – | 833,330 | Form 4 |
| 2026-03-04 | Stepien Thomas MDirector, Chief Executive Officer | Grant or award A | +150,000 | – | 760,000 | Form 4 |
| 2026-01-28 | Stefan Constantin IonelChief Technology Officer | Option exercise M | +90 | 0.62 | 748,786 | Form 4 |
| 2026-01-28 | Stefan Constantin IonelChief Technology Officer | Option exercise M | +39,600 | 0.05 | 788,386 | Form 4 |
| 2026-01-23 | Stefan Constantin IonelChief Technology Officer | Option exercise M | +1,600 | 0.05 | 750,296 | Form 4 |
| 2026-01-22 | Stefan Constantin IonelChief Technology Officer | Option exercise M | +253,928 | 0.05 | 1,002,624 | Form 4 |
| 2026-01-22 | Stefan Constantin IonelChief Technology Officer | Option exercise M | +72,795 | 0.45 | 1,075,419 | Form 4 |
| 2026-01-22 | Stefan Constantin IonelChief Technology Officer | Option exercise M | +166,104 | 0.05 | 1,241,523 | Form 4 |
| 2026-01-21 | Stefan Constantin IonelChief Technology Officer | Option exercise M | +41,563 | 0.62 | 790,259 | Form 4 |
| 2026-01-21 | Stefan Constantin IonelChief Technology Officer | Option exercise M | +15,834 | 0.05 | 806,093 | Form 4 |
| 2026-01-21 | Stefan Constantin IonelChief Technology Officer | Option exercise M | +15,883 | 0.05 | 821,976 | Form 4 |
| 2026-01-20 | Sun KangDirector | Option exercise M | +43,185 | 1.78 | 1,446,836 | Form 4 |
| 2026-01-16 | Sun KangDirector | Option exercise M | +850,338 | 2.50 | 2,253,989 | Form 4 |
| 2026-01-16 | Sun KangDirector | Option exercise M | +100,210 | 1.78 | 2,354,199 | Form 4 |
| 2026-01-12 | Sun KangDirector | Option exercise M | +180,802 | 0.62 | 1,584,453 | Form 4 |
| 2026-01-12 | Sun KangDirector | Option exercise M | +208,264 | 2.44 | 1,792,717 | Form 4 |
| 2026-01-12 | Sun KangDirector | Option exercise M | +117,201 | 2.50 | 1,909,918 | Form 4 |
| 2025-12-19 | Stepien Thomas MDirector, Chief Executive Officer | Grant or award A | +200,000 | – | 760,000 | Form 4/A |
| 2025-12-11 | Stefan Constantin IonelChief Technology Officer | Option exercise M | +125,000 | 0.05 | 946,951 | Form 4 |
| 2025-11-17 | Sun KangDirector, Chief Executive Officer | Option exercise M | +202,934 | 0.98 | 1,675,240 | Form 4 |
| 2025-11-17 | Sun KangDirector, Chief Executive Officer | Option exercise M | +727,950 | 0.05 | 2,403,190 | Form 4 |
| 2025-11-17 | Sun KangDirector, Chief Executive Officer | Option exercise M | +27,463 | 0.62 | 2,430,653 | Form 4 |
| 2025-11-17 | Sun KangDirector, Chief Executive Officer | Option exercise M | +41,653 | 0.62 | 2,472,306 | Form 4 |
| 2025-10-06 | Rodriguez Ricardo C.Chief Financial Officer | Grant or award A | +200,000 | – | 200,000 | Form 4 |
| 2025-06-13 | Chu StevenDirector | Grant or award A | +44,444 | – | 189,839 | Form 4 |
| 2025-06-13 | Bayless Kathleen ADirector | Grant or award A | +44,444 | – | 205,697 | Form 4 |
| 2025-06-13 | Satterthwaite LivingstonDirector | Grant or award A | +44,444 | – | 336,083 | Form 4 |
| 2025-06-13 | Dixon Donald RDirector | Grant or award A | +44,444 | – | 394,656 | Form 4 |
| 2025-06-13 | Hsieh Wen HsuanDirector | Grant or award A | +44,444 | – | 187,339 | Form 4 |
| 2025-05-01 | Stepien Thomas MDirector, President | Grant or award A | +400,000 | – | 400,000 | Form 4 |
| 2025-03-19 | Sun KangDirector, Chief Executive Officer | Grant or award A | +599,400 | – | 1,882,021 | Form 4 |
| 2025-03-19 | Wallach SandraChief Financial Officer | Grant or award A | +383,260 | – | 1,061,260 | Form 4 |
| 2025-03-19 | Stefan Constantin IonelChief Technology Officer | Grant or award A | +461,540 | – | 886,500 | Form 4 |
| 2025-03-14 | Stefan Constantin IonelChief Technology Officer | Option exercise M | +3,471 | 0.98 | 424,960 | Form 4 |
| 2025-03-10 | Bornstein JonathanPresident of Amprius Lab | Option exercise M | +3,471 | 0.98 | 422,668 | Form 4 |
| 2024-10-23 | Amprius, Inc.10% owner | Other J | −5,500,000 | – | 59,695,997 | Form 4 |
| 2024-10-23 | Amprius, Inc.10% owner | Other J | −57,195,926 | – | 2,500,071 | Form 4 |
How to read it
- Buy, sale
- Code P and S on the form: shares bought or sold in the market, at the market price. The other codes are mostly pay (a grant, an option exercised) or tax (shares the company withheld), and say little about what the insider thinks of the price.
- Plan
- A sale or purchase under a Rule 10b5-1 plan, set up in advance and running on its own schedule. Since April 2023 the form has a box for it. Much executive selling is planned and says more about diversifying than about the company.
- Holds after
- The shares the insider still held after the trade, in the form the trade was in (directly, or indirectly through a trust or a fund).
- Value
- Shares times the price the form reports, which is often an average over several fills on the day.
Read from the SEC's own quarterly data sets of Forms 3, 4 and 5, and from each day's filings since the last one. A correcting amendment replaces the lines it restates. Every row links to its filing. None of this is advice: insiders sell for many reasons, and buy for fewer.